Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Jackson

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Molecular Cancer Research : MCR|October 20, 2011
Inhibition of DNA-dependent protein kinase induces accelerated senescence in irradiated human cancer cellsArun Azad, Susan Jackson, Carleen Cullinane, et al.
British Journal of Clinical Pharmacology|October 30, 2023
Adopting human factors in early phase and experimental medicine research: A nested pilot study observing controlled human infection with SARS-CoV-2Helen E Higham, Lauren Morgan, Cushla Cooper, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2011
Differential (18)F-FDG and 3'-deoxy-3'-(18)F-fluorothymidine PET responses to pharmacologic inhibition of the c-MET receptor in preclinical tumor modelsCarleen Cullinane, Donna S Dorow, Susan Jackson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 2020
Therapeutic Efficacy of a Bivalent Inhibitor of Prostate-Specific Membrane Antigen Labeled with <sup>67</sup>CuLachlan E McInnes, Carleen Cullinane, Peter D Roselt, et al.
BMC Medical Informatics and Decision Making|August 8, 2020
Using creative co-design to develop a decision support tool for people with malignant pleural effusionCheryl Grindell, Angela Tod, Remi Bec, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2020
Peptide Receptor Radionuclide Therapy with <sup>67</sup>Cu-CuSarTATE Is Highly Efficacious Against a Somatostatin-Positive Neuroendocrine Tumor ModelCarleen Cullinane, Charmaine M Jeffery, Peter D Roselt, et al.
Cancers|December 24, 2021
Enhancing Adoptive Cell Transfer with Combination BRAF-MEK and CDK4/6 Inhibitors in MelanomaPeter Kar Han Lau, Carleen Cullinane, Susan Jackson, et al.
Environmental and Molecular Mutagenesis|March 29, 2002
Making epidemiologic studies responsive to the needs of participants and communities: the Carolina Breast Cancer Study experiencePatricia Plummer, Susan Jackson, Jamie Konarski, et al.
Inflammatory Bowel Diseases|September 7, 2016
Investigator-Initiated IBD Trials in the United States: Facts, Obstacles, and AnswersHans H Herfarth, Susan Jackson, Barbara G Schliebe, et al.
Frontiers in Immunology|November 29, 2024
A dose escalation study to evaluate the safety of an aerosol BCG infection in previously BCG-vaccinated healthy human UK adultsTimothy Fredsgaard-Jones, Stephanie A Harris, Hazel Morrison, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Molecular Cancer Research : MCR|October 20, 2011
Inhibition of DNA-dependent protein kinase induces accelerated senescence in irradiated human cancer cellsArun Azad, Susan Jackson, Carleen Cullinane, et al.
British Journal of Clinical Pharmacology|October 30, 2023
Adopting human factors in early phase and experimental medicine research: A nested pilot study observing controlled human infection with SARS-CoV-2Helen E Higham, Lauren Morgan, Cushla Cooper, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2011
Differential (18)F-FDG and 3'-deoxy-3'-(18)F-fluorothymidine PET responses to pharmacologic inhibition of the c-MET receptor in preclinical tumor modelsCarleen Cullinane, Donna S Dorow, Susan Jackson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 2020
Therapeutic Efficacy of a Bivalent Inhibitor of Prostate-Specific Membrane Antigen Labeled with <sup>67</sup>CuLachlan E McInnes, Carleen Cullinane, Peter D Roselt, et al.
BMC Medical Informatics and Decision Making|August 8, 2020
Using creative co-design to develop a decision support tool for people with malignant pleural effusionCheryl Grindell, Angela Tod, Remi Bec, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2020
Peptide Receptor Radionuclide Therapy with <sup>67</sup>Cu-CuSarTATE Is Highly Efficacious Against a Somatostatin-Positive Neuroendocrine Tumor ModelCarleen Cullinane, Charmaine M Jeffery, Peter D Roselt, et al.
Cancers|December 24, 2021
Enhancing Adoptive Cell Transfer with Combination BRAF-MEK and CDK4/6 Inhibitors in MelanomaPeter Kar Han Lau, Carleen Cullinane, Susan Jackson, et al.
Environmental and Molecular Mutagenesis|March 29, 2002
Making epidemiologic studies responsive to the needs of participants and communities: the Carolina Breast Cancer Study experiencePatricia Plummer, Susan Jackson, Jamie Konarski, et al.
Inflammatory Bowel Diseases|September 7, 2016
Investigator-Initiated IBD Trials in the United States: Facts, Obstacles, and AnswersHans H Herfarth, Susan Jackson, Barbara G Schliebe, et al.
Frontiers in Immunology|November 29, 2024
A dose escalation study to evaluate the safety of an aerosol BCG infection in previously BCG-vaccinated healthy human UK adultsTimothy Fredsgaard-Jones, Stephanie A Harris, Hazel Morrison, et al.
Pageof 5